Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness

Completed · Not applicable

Conditions studied: Traumatic Brain Injury

In brief

The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.

Key facts

Study ID

NCT02025439

Run by

Edward Hines Jr. VA Hospital

People needed

4

Starts

2014-02-01

Expected to finish

2016-07-01

Last updated by the study team

2020-08-24

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-64 years of age
• Suffered a severe brain injury of traumatic origin at least 1-year prior to study enrollment
• Remain in a state of disordered consciousness
• Brain injuries will include injury with resulting coup-contre-coup injuries, excluding persons with trauma due to blunt injuries and/or non-traumatic encephalopathy

You may not qualify if…

• Have 1 or more Amantadine contraindications: On monoamino oxidase inhibitor-B, hypersensitivity/idiosyncrasy to sympathomimetic amines, uncontrolled hypertension, glaucoma or Congestive Heart Failure
• Have contraindications to Amantadine Dose of 200 mg Daily as determined by estimated Glomerular Filtration Rate (eGFR) ≤ 60 (ml/min)
• Abnormal results of Liver Function Test at screening
• Receiving anti-epileptic medications to control active seizures or have had a documented seizure within three months of study enrollment
• Incurred large cortically based ischemic infarction/encephalomalacia subsequent to TBI
• Have documented history of previous TBI, psychiatric illness (DSM criteria) and/or organic brain syndrome such as Alzheimer's
• Are using medications which may interfere with Amantadine and cannot be safely titrated or discontinued
• Are pregnant
• Have implanted cardiac pacemaker or defibrillator, cochlear implant, nerve stimulator, intracranial metal clips
• Have MRI and/or TMS contraindications such as: History of claustrophobia, metal in eyes/face, shrapnel/bullet remnants in brain
• Are fully conscious as indicated by a score of 6 on the Motor Function scale and/or a score of 2 on the Communication scale of the CRS-R,
• Are within first year of injury
• Are <18 years of age and > 65 years of age
• Have an injury or condition due to blunt trauma only or non-traumatic encephalopathy
• Have programmable CSF shunt or are ventilator dependent

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States
• Edward Hines, Jr. VA Hospital — Hines, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.